Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Copper Histidine Therapy in Menkes Disease
NCT00001262Phase 2Completed
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Start
- Jun 1990
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of copper histidine in Menkes disease, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development. Primary endpoints: Gross Motor Development, Fine Motor Adaptive Development and 2 more. Started Jun 1990; status: completed.
02
Drugs
copper histidine
03
Conditions
Menkes disease
Beyond the preview
Go deeper on NCT00001262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001262.